‌

Supported via arm's length funding from MSD.

Highlights from

The European Congress of Clinical Microbiology & Infectious Diseases

29th Annual Meeting

Amsterdam 13-16 April 2019

Articles

Technology to reduce unnecessary antibiotic prescribing

Neural networks can improve empirical antibiotic prescribing

Do rapid diagnostic tests in respiratory infection reduce unnecessary antibiotic prescribing?

Latest updates on vaccines

Promising phase II results for pneumococcal vaccine in 60-64 year olds

HPV vaccination: a success story but with more work still more to do

Alternative treatment paradigms

Should we be using biomarkers to tailor sepsis treatment to the individual?

Could immune checkpoint inhibitors be used in infectious disease?

Host-defence peptides: a possible alternative to antibiotics?

Finding a cure for hepatitis B is a ‘dream’, but novel therapies show considerable promise

Late-stage and approved therapies

An update on antibiotic pipeline developments

Novel oral antifungal shows favourable response in patients with refractory fungal disease

Bedaquiline-based regimens are effective and safe for MDR-TB but resistance is emerging

Future considerations

Gut microbiome influences efficacy of immunotherapy

Climate change is increasing the reach of vector-borne diseases

Top image: © iStockPhoto nicolas_

The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.

Supported by